Lossi L
Clinical Trial Dosing Ranges Dose Titration Schedules Clinical trials have employed gradual dose escalation to minimize gastrointestinal side effects [9] : Standard Titration Protocol (Example from ONWARDS 1) Rationale: Gradual titration allows tolerance development to gastrointestinal effects (particularly nausea) while building up to therapeutic doses
This study was supported by an AMED grant (JP19ck0106374), by the National Cancer Center Research and Development Fund (2020-A-6), and by the Ono Pharmaceutical Corporation (C2018-130)
Investigated as a research pairing because the two peptides are studied at largely non-overlapping targets, allowing combined exploration of growth-factor and cytoskeletal pathways in the same model
CONCLUSION AND FURTHER PROSPECTS HMs toxicity is now a global problem for agricultural plants, soils, the environment, and human health
In terms of skin benefits, it reduces melanin production, which may result in a brighter and more even complexion over time
